DRGEM manufactures three types of finished products: diagnostic analog X-ray imaging devices, diagnostic digital X-ray imaging devices, and imaging systems that improve analog methods to digital methods.
It is a specialized company in diagnostic X-ray imaging devices that not only produces finished X-ray imaging devices but also develops key components used in these finished devices in-house.
DRGEM's greatest strength lies in designing and developing most of the major components itself, giving it a competitive edge over rivals in terms of quality and cost.
Patent attorney Eom Jeong-han from BLT Patent Law Firm reviewed DRGEM's patent and trademark application status.
Listed companies on the domestic stock market disclose patent acquisition information through the Financial Supervisory Service's electronic disclosure system. However, many stock investors tend to overlook patent disclosures.
Not only patents but also trademark registrations indicate the future direction of listed companies, making them one of the important indicators for assessing future corporate value. Some patent disclosures even act as direct triggers for stock price increases.
It is not easy for ordinary investors to understand the impact on companies through patent disclosures or to check trademark application statuses one by one. Asia Economy, together with patent attorney Eom Jeong-han from BLT Patent Law Firm, is reviewing the patent and trademark application status of listed companies through 'Special Express Train.'
'Special Express Train' is an abbreviation for a broadcast that diligently searches for stocks surging due to patents.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
